Virtual Venture & IP Conference panel highlights life science ventures and COVID

Virtual Venture & IP Conference panel highlights life science ventures and COVID

How are life science ventures leveraging their technologies to help mitigate the spread and virulence of the novel coronavirus? The Invent Penn State Venture & IP Conference panel “Life Science Ventures Addressing COVID-19” will explore this topic from 4:25-5:20 p.m. on Thursday, April 15. Registration for the all-virtual Invent Penn State Venture & IP Conference, happening April 15-16, is currently open to the public. Panel members include: Teresa Whalen – CEO, CytoAgents Inc.: As a biotech innovator, health care technology leader, life sciences investor and clinical pharmacist, Whalen has a successful track record of bringing life-changing health care products to market. Read more >>

Share this post